| Flight Centre Travel Group Limited (FLT) ORDINARY FULLY PAID |
Consumer Discretionary |
$2,841 |
FY25 Half Year Investor Pres. (inc guidance commentary)
|
26 Feb 2025 8:19AM |
$17.720 |
$13.370 |
fallen by
24.55%
|
|
FLT - Price-sensitive ASX Announcement
Full Release
Key Points
- 1H growth across key financial metrics including TTV, revenue and underlying profit.
- Record corporate TTV exceeds pre-COVID levels.
- Strong international ticket volume growth in Australia.
- Underlying profit before tax achieved of $117 million, up 7%.
- Expectations for a strong second half with earnings skewed due to seasonal trends.
- Solid pipeline of new account wins estimated at $800 million for FCM.
- Corporate Traveller securing a large volume of smaller accounts driving TTV growth.
- Investment in digital platforms delivering strong returns.
- FY25 guidance maintained with a target UPBT between $365 million and $405 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Appen Limited (APX) ORDINARY FULLY PAID |
Information Technology |
$360 |
2024 Annual Report
|
26 Feb 2025 8:19AM |
$2.880 |
$1.355 |
fallen by
52.95%
|
|
| Orora Limited (ORA) ORDINARY FULLY PAID |
Materials |
$2,825 |
Update - Notification of buy-back - ORA
|
26 Feb 2025 8:18AM |
$2.120 |
$2.290 |
risen by
8.02%
|
|
| EZZ Life Science Holdings Limited (EZZ) ORDINARY FULLY PAID |
Health Care |
$71 |
Half Yearly Report and Accounts
|
26 Feb 2025 8:18AM |
$2.010 |
$1.510 |
fallen by
24.88%
|
|
EZZ - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 39.6% to $30.3 million.
- Profit after tax rose by 179.9% to $3.2 million.
- EZZ launched eight new health and wellness products.
- Achieved an 84% increase in revenue during the 2024 11.11 Global Shopping Festival.
- Preparing to enter the US market in the second half of FY25.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Appen Limited (APX) ORDINARY FULLY PAID |
Information Technology |
$360 |
Appendix 4E
|
26 Feb 2025 8:17AM |
$2.880 |
$1.355 |
fallen by
52.95%
|
|
APX - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue and other income down 14% to $235,705,000.
- Loss improved by 83.1% to $20,009,000.
- No final dividend declared for the year ended 31 December 2024.
- No current dividend reinvestment plan in place.
- Net tangible assets per ordinary security increased from 25.03 to 32.27 US cents.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Flight Centre Travel Group Limited (FLT) ORDINARY FULLY PAID |
Consumer Discretionary |
$2,841 |
FY25 Half Year Results Release (inc guidance commentary)
|
26 Feb 2025 8:17AM |
$17.720 |
$13.370 |
fallen by
24.55%
|
|
FLT - Price-sensitive ASX Announcement
Full Release
Key Points
- $11.7b in TTV, up 3% (circa $365m)
- $117m UPBT, 7% YoY increase – outpacing TTV growth
- 11c fully franked interim dividend (up 10%)
- Solid 2Q recovery after challenging 1Q
- 14% 2Q UPBT growth achieved off 7% 2Q TTV growth
- Corporate business delivered record TTV, 143% of pre-pandemic size
- Leisure segment more productive and profitable than pre-COVID
- Guidance reaffirmed with heavy 2H profit weighting expected
- 2.3%+ UPBT margin in Australia in January 2025
- Continued investment in AI and cruise sector
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cuscal Limited (CCL) ORDINARY FULLY PAID |
Financials |
$799 |
1H FY25 Results Announcement
|
26 Feb 2025 8:17AM |
$2.560 |
$4.170 |
risen by
62.89%
|
|
CCL - Price-sensitive ASX Announcement
Full Release
Key Points
- Statutory NPAT decreased by 11% to $12.2 million for December 2024.
- Pro forma NPAT increased by 42% to $21.5 million.
- Transaction volume growth of 7% supporting financial metrics.
- Total adjusted net operating income rose by 6% to $146.7 million.
- Pro forma adjusted EBITDA increased by 21% to $35.6 million.
- Well capitalised and strong balance sheet indicate capacity for growth.
- Focus for the second half of FY25 will be on strengthening core capabilities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Flight Centre Travel Group Limited (FLT) ORDINARY FULLY PAID |
Consumer Discretionary |
$2,841 |
FY25 Half Year Accounts
|
26 Feb 2025 8:16AM |
$17.720 |
$13.370 |
fallen by
24.55%
|
|
FLT - Price-sensitive ASX Announcement
Full Release
Key Points
- FLT reported a 7% YoY growth in UPBT for FY25 first half.
- Total transaction value increased by $365 million to $11.7 billion.
- Corporate business contributed a record $6 billion to TTV.
- Leisure business recorded a $5.5 billion contribution to TTV.
- FLT is investing in AI to enhance productivity and customer offerings.
- Directors declared an interim dividend of 11 cents per share.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Integral Diagnostics Limited (IDX) ORDINARY FULLY PAID |
Health Care |
$880 |
FY25 Half Year Results Media Release
|
26 Feb 2025 8:16AM |
$2.860 |
$2.360 |
fallen by
17.48%
|
|
IDX - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue growth of 7.8% to AUD 249.4 million
- Operating EBITDA increased by 8.2%
- Operating NPAT growth of 31.9%
- Net debt-to-EBITDA ratio of 2.8x
- Declared fully franked dividend of 2.5 cents per share
- Positive outlook for the radiology industry supported by regulatory changes
- Merger with Capitol Health expected to generate significant synergies
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cuscal Limited (CCL) ORDINARY FULLY PAID |
Financials |
$799 |
Appendix 4D and 1H FY25 Financial Report
|
26 Feb 2025 8:16AM |
$2.560 |
$4.170 |
risen by
62.89%
|
|
CCL - Price-sensitive ASX Announcement
Full Release
Key Points
- Consolidated profit attributable to owners decreased 11% to $12.2 million compared to the prior year.
- Financial results impacted by $9.3 million in costs associated with the IPO.
- Total net operating income increased by 7% to $146.7 million.
- Operating expenses rose by 11% to $129.2 million.
- Cuscal has paid a special dividend of 4.5 cents per share for the half year ending December 2024.
- The company is on track to meet or exceed FY25 profit forecasts.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Kelsian Group Limited (KLS) ORDINARY FULLY PAID |
Industrials |
$1,147 |
1HFY25 Results Investor Presentation
|
26 Feb 2025 8:15AM |
$3.620 |
$4.225 |
risen by
16.71%
|
|
KLS - Price-sensitive ASX Announcement
Full Release
Key Points
- 1HFY25 financial performance in line with expectations.
- Targeting underlying EBITDA between $283 million and $295 million for FY25.
- Revenue increased by 9.1% to $1,071.8 million.
- Underlying EBITDA rose by 1.3% to $132.2 million.
- Underlying NPATA decreased by 7.9% to $39.7 million.
- Cash conversion remains strong at 93%.
- Interim dividend maintained at 8.0 cents per share.
- Capital management and allocation framework completed.
- Ongoing portfolio review to improve returns.
- Focus on disciplined growth strategy.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Aurelia Metals Limited (AMI) ORDINARY FULLY PAID |
Materials |
$516 |
Dec 2024 Half Year Financial Results Presentation
|
26 Feb 2025 8:14AM |
$0.215 |
$0.305 |
risen by
41.86%
|
|
AMI - Price-sensitive ASX Announcement
Full Release
Key Points
- Underlying NPAT increased to $15.6 million from a loss of $1.8 million.
- Underlying EBITDA rose by 53% to $49.7 million.
- Cash balance at $96.7 million with no drawn debt.
- Gold production decreased to 21.5k oz from 31.7k oz.
- Improved copper and zinc production with positive operational performance.
- Focus on productivity improvements and ramping up Federation operations.
- Significant opportunity for growth through planned exploration and optimization projects.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ReadyTech Holdings Limited (RDY) ORDINARY FULLY PAID |
Information Technology |
$198 |
Half Year Results - Investor Presentation
|
26 Feb 2025 8:14AM |
$3.300 |
$1.605 |
fallen by
51.36%
|
|
RDY - Price-sensitive ASX Announcement
Full Release
Key Points
- Total revenue increased by 6.6% to $58.3 million.
- Underlying EBITDA rose by 4.6% to $18.2 million.
- Subscription revenue grew by 5.7% to $49.9 million.
- Total cash EBITDA margin improved to 14.7%.
- Received largest contract win exceeding $1 million in Workforce Solutions.
- Acquisition of CouncilWise enhances local government service capabilities.
- AI solutions such as Talent IQ and Ask AI Policy Bot were launched.
- Confidence in a $37.5 million opportunity pipeline.
- Expectations for margin expansion in 2H FY25.
- Strong cash flow and balance sheet support further growth initiatives.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Aurelia Metals Limited (AMI) ORDINARY FULLY PAID |
Materials |
$516 |
Dec 2024 Half Year Financial Results
|
26 Feb 2025 8:14AM |
$0.215 |
$0.305 |
risen by
41.86%
|
|
AMI - Price-sensitive ASX Announcement
Full Release
Key Points
- Underlying EBITDA increased 53% to $49.7M.
- Statutory net profit after tax improved 984% to $18.0M.
- Cash flows from operating activities increased 55% to $53.1M.
- Strong cash balance of $96.7M with operations funding all growth capital.
- Group All-In-Sustaining-Cost margin increased 70% to $1,557/oz.
- Federation mine development increased to 1,491 metres.
- First production from Federation with 16.5kt ore processed at the Peak plant.
- Cobar Optimisation study completed recommending expansion of Peak plant.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Kelsian Group Limited (KLS) ORDINARY FULLY PAID |
Industrials |
$1,147 |
1HFY25 Half Year Results & Capital Management Framework
|
26 Feb 2025 8:14AM |
$3.620 |
$4.225 |
risen by
16.71%
|
|
KLS - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue up 9.1% to $1,071.8 million
- Underlying EBITDA up 1.3% to $132.2 million
- Underlying NPATA down 7.9% to $39.7 million
- Statutory Net Profit After Tax was $20.1 million
- Fully franked interim dividend of 8.0 cents per share
- Successful launch of Bankstown Rail Replacement service
- Renewed Bunbury & Busselton bus services contract worth $100 million
- Announced capital management framework targets
- Sale of three bus depots in Western Australia expected to realize ~$20.3 million
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Latitude Group Holdings Limited (LFS) ORDINARY FULLY PAID |
Financials |
$967 |
Update - Notification of buy-back - LFSPA
|
26 Feb 2025 8:14AM |
$1.200 |
$0.930 |
fallen by
22.50%
|
|
| Southern Cross Gold Consolidated Ltd (SX2) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$2,763 |
SX2 High-Grade Gold-Antimony Extends 200m West at Christina
|
26 Feb 2025 8:14AM |
$3.610 |
$10.670 |
risen by
195.57%
|
|
SX2 - Price-sensitive ASX Announcement
Full Release
Key Points
- High-grade gold-antimony mineralization extended by 200 meters west at Christina.
- Mineralized strike length now totals 1.5 km between Apollo East and Christina.
- New vein sets discovered, indicating further potential for mineralization.
- Drillhole SDDSC148 achieved multiple high-grade intersections.
- Upcoming catalysts include exploration target upgrades and ongoing expansion drilling.
- Project's significance increased due to China's export restrictions on antimony.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Credit Clear Limited (CCR) ORDINARY FULLY PAID |
Information Technology |
$123 |
1HY FY25 Investor Presentation
|
26 Feb 2025 8:13AM |
$0.285 |
$0.235 |
fallen by
17.54%
|
|
| Credit Clear Limited (CCR) ORDINARY FULLY PAID |
Information Technology |
$123 |
1H FY25 Results Summary
|
26 Feb 2025 8:13AM |
$0.285 |
$0.235 |
fallen by
17.54%
|
|
| Credit Clear Limited (CCR) ORDINARY FULLY PAID |
Information Technology |
$123 |
Half Yearly Report and Accounts
|
26 Feb 2025 8:13AM |
$0.285 |
$0.235 |
fallen by
17.54%
|
|
CCR - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 16% to $23.249 million.
- Net loss after tax was $2.174 million.
- Previous year's loss was $2.102 million.
- Strong onboarding of new clients contributed to revenue growth.
- The company focuses on digital collection technologies.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Aurelia Metals Limited (AMI) ORDINARY FULLY PAID |
Materials |
$516 |
Appendix 4D & Dec 2024 Half Year Financial Results
|
26 Feb 2025 8:13AM |
$0.215 |
$0.305 |
risen by
41.86%
|
|
AMI - Price-sensitive ASX Announcement
Full Release
Key Points
- Aurelia Metals Limited achieved a statutory net profit of $18.0 million for H1 FY25.
- The Federation Mine reached first production, contributing positively to the financial results.
- Dargues Mine ceased operations in August 2024, impacting overall production and costs.
- Peak Mine showed increased production with a gross profit of $32.1 million.
- Strong EBITDA growth was reported, reflecting improved operational performance.
- Focus on enhancing infrastructure and processing capabilities in the Cobar Basin.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Apiam Animal Health Limited (AHX) ORDINARY FULLY PAID |
Health Care |
$164 |
Half Yearly Report and Accounts
|
26 Feb 2025 8:13AM |
$0.415 |
$0.875 |
risen by
110.84%
|
|
AHX - Price-sensitive ASX Announcement
Full Release
Key Points
- Group revenue increased to $106.2 million, up 1.7% from the previous year.
- Net profit after tax attributable to members was a loss of $1.5 million.
- The Clinical Vet Services segment's revenue declined due to paused dairy heifer exports to China.
- Apiam plans to divest underperforming clinics and has entered acquisition discussions for new clinics.
- An impairment charge of $4.5 million was recognized related to business divestments.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Botanix Pharmaceuticals Ltd (BOT) ORDINARY FULLY PAID |
Health Care |
$109 |
Appendix 4D and Half Year Report
|
26 Feb 2025 8:13AM |
$0.505 |
$0.056 |
fallen by
89.01%
|
|
BOT - Price-sensitive ASX Announcement
Full Release
Key Points
- Botanix Pharmaceuticals is a clinical dermatology company marketing Sofdra, a treatment for primary axillary hyperhidrosis.
- The company reported a net loss of $30,888,119 for the half-year ended 31 December 2024.
- Sofdra was approved by the FDA on June 18, 2024, and initial prescriptions began in December 2024.
- Botanix incurred significant expenses in sales and marketing, totaling $8,862,001.
- The company expects Q1 2025 to be the first quarter of commercial revenue from Sofdra.
- Botanix has engaged 27 territory managers for the Sofdra launch and has completed sales training.
- The company has finalized terms with US commercial payers, making Sofdra accessible to 167 million lives.
- A successful Patient Experience Program provided insights for the broader product launch.
- The report indicates a material uncertainty regarding the company's ability to continue as a going concern.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ReadyTech Holdings Limited (RDY) ORDINARY FULLY PAID |
Information Technology |
$198 |
Half Year Results - Media Release
|
26 Feb 2025 8:12AM |
$3.300 |
$1.605 |
fallen by
51.36%
|
|
RDY - Price-sensitive ASX Announcement
Full Release
Key Points
- Total revenue increased 6.6% to $58.3 million for 1H FY25
- Recurring revenue represented 85.6% of total revenue
- Net revenue retention was 102%
- Underlying EBITDA grew by 4.6% to $18.2 million
- Strong contributions from Education and Workforce Solutions
- Enterprise pipeline exceeds $37.5 million
- Strategic contract wins include entry into the University market
- Investment in R&D and Sales & Marketing at 29% and 8.6% of revenue respectively
- Expectations for double-digit growth in key segments
- Focus on innovation and AI-enhanced solutions
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| MAAS Group Holdings Limited (MGH) ORDINARY FULLY PAID |
Industrials |
$1,458 |
Update - Notification of buy-back - MGH
|
26 Feb 2025 8:12AM |
$3.560 |
$4.040 |
risen by
13.48%
|
|
Call 1300 880 160
Start a chat
Schedule a call
